ClinicalTrials.gg

MorphoSys AG clinical trials

Acquired by Novartis, May 23, 2024 · source ↗

The registry lists 11 studies whose lead sponsor is MorphoSys AG. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2024.

Before and after it joined Novartis

First submitted before MorphoSys AG became part of Novartis
11
First submitted after MorphoSys AG became part of Novartis
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs MorphoSys AG’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 11 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed982%
  • Stopped early19%
  • Status unknown or other19%

Phase

  • Phase 27
  • Phase 14

Where

  • Germany8
  • United States7
  • Italy6
  • Spain5
  • Poland5
  • Austria4

Over the years

  1. 09
  2. 10
  3. 11
  4. 12
  5. 213
  6. 14
  7. 15
  8. 16
  9. 17
  10. 18
  11. 19
  12. 20
  13. 21
  14. 22
  15. 23
  16. 24
  17. 25
  18. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • MorphoSys AG11 studies

Something wrong with this grouping? Tell us on the Novartis page.

Studies

Recruiting first, then most recently updated. Showing 11 of 11. All Novartis studies →